1415456-99-3

1415456-99-3 structure
1415456-99-3 structure
  • Name: Cagrilintide
  • Chemical Name: Cagrilintide
  • CAS Number: 1415456-99-3
  • Molecular Formula: C194H312N54O59S2
  • Molecular Weight: 4409
  • Catalog: Signaling Pathways GPCR/G Protein CGRP Receptor
  • Create Date: 2022-08-31 23:22:54
  • Modify Date: 2026-07-03 13:38:57
  • Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity[1][2][3].

Name Cagrilintide
Description Cagrilintide is an investigational novel long-acting acylated amylin analogue, acts as nonselective amylin receptors (AMYR) and calcitonin G protein-coupled receptor (CTR) agonist. Cagrilintide induces significant weight loss and reduces food intake. Cagrilintide has the potential for the research of obesity[1][2][3].
Related Catalog
In Vivo Cagrilintide (compound 23) (0.1, 1, 3, 10, 30 nmol/kg; s.c.) reduces food intake in the rat[2]. Cagrilintide (10 nmol/kg; i.v. or s.c.) shows good pharmacokinetic parameters[2]. Animal Model: 12 weeks, 400 g Sprague Dawley male rats[2] Dosage: 0.1, 1, 3, 10, 30 nmol/kg Administration: S.c.; once for 80 h Result: Reduced food intake in the rat for several days at doses in the range of 1-10 nmol/kg. Animal Model: 12 weeks, 400 g Sprague Dawley male rats[2] Dosage: 10 nmol/kg Administration: I.v.; s.c. Result: Showed good pharmacokinetic parameters with T1/2 of 20±2, 27±3 h for i.v. and s.c., respectively.
References

[1]. Fletcher MM, et al. AM833 Is a Novel Agonist of Calcitonin Family G Protein-Coupled Receptors: Pharmacological Comparison with Six Selective and Nonselective Agonists. J Pharmacol Exp Ther. 2021 Jun;377(3):417-440.

[2]. Kruse T, et al. Development of Cagrilintide, a Long-Acting Amylin Analogue. J Med Chem. 2021 Aug 12;64(15):11183-11194.

[3]. Dehestani B, et al. Amylin as a Future Obesity Treatment. J Obes Metab Syndr. 2021 Dec 30;30(4):320-325.

Molecular Formula C194H312N54O59S2
Molecular Weight 4409
Exact Mass 4408.2582207
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.